Global results from Accountable Care, Frugal Innovation have potential for US policy

The November issue of the journal Health Affairs highlights three studies from Duke University and collaborators that examine implementation of accountable care worldwide and lay out key lessons from a global analysis of accountable care reforms and frugal innovations that could improve healthcare delivery and outcomes in the United States. Read More

Enhancing Primary Care and Cardiology Collaboration Through Payment Reform

In a review published November 22 in JAMA Cardiology , the Duke-Margolis Center for Health Policy and professional societies representing primary care and cardiology describe a conceptual approach to more effective collaboration between cardiology and primary care physicians in treating patients with chronic cardiovascular disease (CVD).

Cardiovascular disease is the leading cause of death in the United States and accounts for 17 percent of national health expenditures. Treating CVD can be challenging for both primary-care and specialized physicians and their patients. The authors argue that these challenges must be addressed through a collaborative approach to delivering CVD care and describe payment reforms that can support effective collaborative care models in a wide range of clinical circumstances. The new approach can clarify clinical roles and responsibilities, improve both the patient and physician experience, as well as health outcomes, while avoiding unnecessary costs.

“This work reflects a special collaboration between the Duke-Margolis Center for Health Policy and professional societies representing primary care and cardiology to address the need for an alternative payment model for collaborative management of chronic cardiovascular disease,” said center director and study co-author Mark McClellan, MD, PhD. Read More

Health Affairs Blog: 2016 Medicare ACO Results

Medicare Accountable Care Organization Results For 2016: Seeing Improvement, Transformation Takes Time -- read more from Robert Saunders, David Muhlestein, and Mark McClellan on the Health Affairs Blog.

Sorenson Leads Project to Address Low-Value Health Care

Corinna Sorenson, PhD , has received a grant from the National Pharmaceutical Council to investigate why efforts to eliminate low-value health care in the United States have been largely unsuccessful. Read More

George Cheely, MD , was an invited panelist, speaking on " The Future of Alternative Payment Models" at the Association of American Medical Colleges National Meeting in Boston on November 5.

How do consumers know whether the doctors they need are in network? It's not easy -- read more in the New York Times from Charlene Wong, MD, MSPH.

Duke-Margolis Director Mark McClellan is one of five former FDA Commissioners to argue against an expanded role for the Department of Defense in approving new treatments. Read the full letter at the Center for Science in the Public Interest

Theresa Williamson, MD, Mary Carol Barks, and a team of Duke medical students recently surveyed 140 neurosurgeons at the annual Congress of Neurological Surgeons meeting on October 8 ^th-11 ^th in Boston, MA as part of a research study to understand how neurosurgeons make the emergent and complex decisions to operate on patients that present with severe traumatic brain injury. Read More

On November 1, Margolis Scholar Madhu Vulamiri was a member of a panel on Medicaid hotspotting on WUNC's The State of Things.  Listen here.

FDA’s New Regulatory Framework for Tobacco and Nicotine: the Role of Medicinal Nicotine

December 12, 2017 - 12:30 pm

National Press Club

529 14th Street NW

Washington, DC 20045

This public event will bring together regulators, public health and addiction experts, and advocacy groups to discuss the FDA’s regulatory approach to medicinal nicotine in more depth, and highlight the key outstanding scientific and policy questions that will need to be addressed to support the development and appropriate use of innovative nicotine replacement therapies.

This event will feature a keynote address by FDA Commissioner Scott Gottlieb, followed by a panel discussion that will include Mitchell Zeller, Director of the Center for Tobacco Products at FDA, as well as other experts. Learn More and Register

2018 Sentinel Initiative Annual Public Workshop

February 7, 2018 - 9:00 am

Hyatt Regency Bethesda

1 Bethesda Metro Center

Bethesda, MD 20814

This annual workshop serves as a forum to bring together leading experts and interested stakeholders to discuss the ongoing development of the Sentinel Initiative. The Food and Drug Administration Amendments Act of 2007 authorized the Sentinel Initiative with the charge of utilizing electronic health care data for post market risk identification and analysis of medical product safety. Learn More and Register